| Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis CM Artlett, JB Smith, SA Jimenez New England Journal of Medicine 338 (17), 1186-1191, 1998 | 611 | 1998 |
| Description of 12 cases of nephrogenic fibrosing dermopathy and review of the literature FA Mendoza, CM Artlett, N Sandorfi, K Latinis, S Piera-Velazquez, ... Seminars in arthritis and rheumatism 35 (4), 238-249, 2006 | 350 | 2006 |
| Oligoclonal T cell expansion in the skin of patients with systemic sclerosis LI Sakkas, B Xu, CM Artlett, S Lu, SA Jimenez, CD Platsoucas The Journal of Immunology 168 (7), 3649-3659, 2002 | 278 | 2002 |
| Dialysis‐associated systemic fibrosis (nephrogenic fibrosing dermopathy): study of inflammatory cells and transforming growth factor β1 expression in affected skin SA Jiménez, CM Artlett, N Sandorfi, C Derk, K Latinis, H Sawaya, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2004 | 263 | 2004 |
| The inflammasome activating caspase 1 mediates fibrosis and myofibroblast differentiation in systemic sclerosis CM Artlett, S Sassi‐Gaha, JL Rieger, AC Boesteanu, ... Arthritis & Rheumatism 63 (11), 3563-3574, 2011 | 214 | 2011 |
| Chimeric cells of maternal origin in juvenile idiopathic inflammatory myopathies CM Artlett, R Ramos, SAA Jiminez, K Patterson, FW Miller, LG Rider The Lancet 356 (9248), 2155-2156, 2000 | 201 | 2000 |
| A cohort study of cancer incidence in systemic sclerosis. CT Derk, M Rasheed, CM Artlett, SA Jimenez The Journal of rheumatology 33 (6), 1113-1116, 2006 | 168 | 2006 |
| Mir-155 is overexpressed in systemic sclerosis fibroblasts and is required for NLRP3 inflammasome-mediated collagen synthesis during fibrosis CM Artlett, S Sassi-Gaha, JL Hope, CA Feghali-Bostwick, PD Katsikis Arthritis research & therapy 19, 1-8, 2017 | 130 | 2017 |
| Suppl 1: the role of the NLRP3 inflammasome in fibrosis CM Artlett The open rheumatology journal 6, 80, 2012 | 126 | 2012 |
| IL-15 treatment during acute simian immunodeficiency virus (SIV) infection increases viral set point and accelerates disease progression despite the induction of stronger SIV … YM Mueller, DH Do, SR Altork, CM Artlett, EJ Gracely, CD Katsetos, ... The Journal of Immunology 180 (1), 350-360, 2008 | 125 | 2008 |
| Inflammasomes in wound healing and fibrosis CM Artlett The Journal of pathology 229 (2), 157-167, 2013 | 120 | 2013 |
| Polymorphisms in the IL-1 receptor antagonist gene VNTR are possible risk factors for juvenile idiopathic inflammatory myopathies LG Rider, CM Artlett, CB Foster, A Ahmed, T Neeman, SJ Chanock, ... Clinical & Experimental Immunology 121 (1), 47-52, 2000 | 112 | 2000 |
| Increased numbers of microchimeric cells of fetal origin are associated with dermal fibrosis in mice following injection of vinyl chloride PJ Christner, CM Artlett, RF Conway, SA Jiménez Arthritis & Rheumatism: Official Journal of the American College of …, 2000 | 110 | 2000 |
| Fetal-maternal HLA compatibility confers susceptibility to systemic sclerosis CM Artlett, KI Welsh, CM Black, SA Jimenez Immunogenetics 47, 17-22, 1997 | 97 | 1997 |
| Increased microchimeric CD4+ T lymphocytes in peripheral blood from women with systemic sclerosis CM Artlett, LA Cox, RC Ramos, TN Dennis, RA Fortunato, LK Hummers, ... Clinical Immunology 103 (3), 303-308, 2002 | 89 | 2002 |
| Detection of cellular microchimerism of male or female origin in systemic sclerosis patients by polymerase chain reaction analysis of HLA–Cw antigens CM Artlett, LA Cox, SA Jimenez Arthritis & Rheumatism: Official Journal of the American College of …, 2000 | 88 | 2000 |
| Transforming growth factor β1 (TGFβ1)-induced CD44V6-NOX4 signaling in pathogenesis of idiopathic pulmonary fibrosis S Ghatak, VC Hascall, RR Markwald, C Feghali-Bostwick, CM Artlett, ... Journal of Biological Chemistry 292 (25), 10490-10519, 2017 | 87 | 2017 |
| Precursor of advanced glycation end products mediates ER-stress-induced caspase-3 activation of human dermal fibroblasts through NAD (P) H oxidase 4 DT Loughlin, CM Artlett PloS one 5 (6), e11093, 2010 | 87 | 2010 |
| Microchimerism and systemic sclerosis SA Jimenez, CM Artlett Current opinion in rheumatology 17 (1), 86-90, 2005 | 84 | 2005 |
| Telomere reduction in scleroderma patients: a possible cause for chromosomal instability CM Artlett, CM Black, DC Briggs, CO Stevens, KI WELSH Rheumatology 35 (8), 732-737, 1996 | 81 | 1996 |
